|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Guardant Health, Inc. (GH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
121,380,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,187 |
2,187 |
5,168 |
98,220 |
| Total Buy Value |
$38,963 |
$38,963 |
$136,461 |
$2,585,297 |
| Total People Bought |
1 |
1 |
1 |
2 |
| Total Buy Transactions |
1 |
1 |
2 |
4 |
| Total Shares Sold |
100 |
6,000 |
10,991 |
31,616 |
| Total Sell Value |
$1,905 |
$157,493 |
$334,111 |
$1,291,105 |
| Total People Sold |
1 |
2 |
2 |
3 |
| Total Sell Transactions |
1 |
3 |
6 |
11 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Potter Myrtle S |
Director |
– • – |
2023-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
68 |
7,240 |
|
- |
|
| Joyce Meghan V. |
Director |
– • – |
2023-11-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
66 |
4,456 |
|
- |
|
| Krognes Steve E. |
Director |
– • – |
2023-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,468 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2023-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
68 |
7,172 |
|
- |
|
| Joyce Meghan V. |
Director |
– • – |
2023-10-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
67 |
4,390 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2023-10-01 |
4 |
D |
$29.64 |
$70,276 |
D/D |
(2,371) |
9,348 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,856 |
11,719 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2023-10-01 |
4 |
D |
$29.64 |
$85,126 |
D/D |
(2,872) |
11,369 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,428 |
14,241 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2023-10-01 |
4 |
D |
$29.64 |
$54,923 |
D/D |
(1,853) |
23,683 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,356 |
25,536 |
|
- |
|
| Merrill Amelia |
SVP, People |
• – – |
2023-10-01 |
4 |
D |
$29.64 |
$19,770 |
D/D |
(667) |
26,995 |
|
- |
|
| Merrill Amelia |
SVP, People |
• – – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,928 |
27,662 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2023-10-01 |
4 |
D |
$29.64 |
$63,074 |
D/D |
(2,128) |
13,279 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,713 |
15,407 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2023-10-01 |
4 |
D |
$29.64 |
$39,925 |
D/D |
(1,347) |
20,470 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,895 |
21,817 |
|
- |
|
| Krognes Steve E. |
Director |
– • – |
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
155 |
2,314 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2023-09-28 |
4 |
OE |
$8.80 |
$39,600 |
D/D |
4,500 |
20,180 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2023-09-15 |
4 |
D |
$29.53 |
$12,609 |
D/D |
(427) |
8,891 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2023-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,233 |
9,318 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2023-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
69 |
7,104 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2023-09-12 |
4 |
S |
$32.59 |
$69,254 |
D/D |
(2,125) |
7,813 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2023-09-09 |
4 |
D |
$33.72 |
$33,922 |
D/D |
(1,006) |
15,680 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2023-09-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,908 |
16,686 |
|
- |
|
671 Records found
|
|
Page 4 of 27 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
